Elevated phase amplitude coupling as a depression biomarker in epilepsy.

Area of Science:

• Neuroscience
• Epileptology
• Psychiatry

Background:

• Depression frequently co-occurs with epilepsy, impacting patient quality of life.
• Understanding the neural correlates of comorbid depression in epilepsy is crucial for effective treatment.

Purpose of the Study:

• To investigate brain activity patterns, including spectral power and phase amplitude coupling (PAC), associated with comorbid depression in drug-resistant epilepsy patients.
• To identify electrophysiological biomarkers for depression in epilepsy using intracranial recordings.

Main Methods:

• Case-control comparison of spectral power and PAC in 34 invasively monitored epilepsy patients.
• Correlation of brain activity metrics with Beck Depression Inventory-II (BDI) scores.
• Analysis focused on specific brain regions implicated in depression (e.g., anterior cingulate cortex, amygdala, orbitofrontal cortex).

Main Results:

• An elevated PAC signal in the theta-alpha-beta phase (5-25 Hz) to gamma frequency (80-100 Hz) band was identified in epilepsy patients with high BDI scores.
• This elevated PAC signal was observed in brain regions associated with primary depression.
• No significant difference in spectral power was noted between high and low BDI score groups.

Conclusions:

• Phase amplitude coupling (PAC) demonstrates potential as a network-specific electrophysiological biomarker for comorbid depression in epilepsy.
• PAC may serve as a viable target for neuromodulation therapies aimed at treating depression in epilepsy patients.